Ballard K
, Baxter H. Developments in wound care for difficult to manage wounds. Br J Nurs2000;9:405-408,410,412.
2.
Courtenay M
, Church JC, Ryan TJ. Larva therapy in wound management. J R Soc Med2000;93:72-74.
3.
Drisdelle R.Maggot debridement therapy: a living cure
. Nursing2003;33:17.
4.
Beasley WD
, Hirst G. Making a meal of MRSA—the role of biosurgery in hospital-acquired infection. J Hosp Infect2004;56:6-9.
5.
Sherman RA
, Shimoda KJ. Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection. Clin Infect Dis2004;39:1067-1070.
6.
Mumcuoglu KY
. Clinical applications for maggots in wound care. Am J Clin Dermatol2001;2:219-227.
7.
Thomas S
, Jones M, Wynn K, Fowler T. The current status of maggot therapy in wound healing. Br J Nurs2001;10:S5-S8, S10, S12.
8.
Fleischmann W
, Grassberger M, Sherman R. Maggot therapy: a handbook of maggot-assisted wound healing. New York: Thieme; 2004.
9.
Biological Research Unit.2004. Contraindications and adverse reactions to maggot therapy. Bridgend, UK: Author. Retrieved December 10, 2004, from www.larve.com/maggot_manual/docs/contraindications.html
10.
Maggot Therapy Project
, University of California. 2004. Maggot therapy information sheet for physicians (FAQs). Irvine: Author. Retrieved December 10, 2004, from www.ucihs.uci.edu/com/pathology/sherman/mdt_info.pdf
11.
Thomas S
, Wynn K, Fowler T, Jones M. The effect of containment on the properties of sterile maggots. Br J Nurs [Tissue Viability Suppl]2002;11:S21-S28.
12.
Steenvoorde P
, Jukema GN. The anti-microbial activity of maggots, in vivo-results. J Tissue Viability2004;14:97-101.